Registered Kenya · PPB

SUPRAPROCT SUPPOSITORIES

TRIBENOSIDELIDOCAINE HCL

H2001/13112/0147 TRIBENOSIDE-400MG/SUPPOSITORYLIDOCAINE-40MG/SUPPOSITORY GENERIC/BIOSIMILARS

What it does

Tribenoside and lidocaine is a combination medication used to relieve pain and discomfort in certain conditions.

Commonly used for: pain relief (analgesia), varicose veins, hemorrhoids

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
H2001/13112/0147
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
TRIBENOSIDELIDOCAINE HCL
Strength
-
Pack size
N/A
Therapeutic class
GENERIC/BIOSIMILARS
Manufacturer / MAH
Pharmamed Solution
Country of origin
FOREIGN
Manufacturer location
Muchai Dr, Nairobi, Kenya

Source: Pharmacy and Poisons Board · fetched 2026-01-28 21:01:59 · updated 2026-07-26 13:44:19

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Tribenoside and lidocaine is a combination medication used to relieve pain and discomfort in certain conditions.

What it treats

  • pain relief (analgesia)
  • varicose veins
  • hemorrhoids

How it works

Tribenoside helps improve blood flow and reduce swelling, while lidocaine numbs the area to decrease pain.

Who it's for

This medication is for adults experiencing pain or discomfort from conditions like varicose veins and hemorrhoids.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: tribenosidelidocaine

Tribenoside-lidocaine is a combination medication that combines the venotonic agent tribenoside, which is used to treat venous insufficiency, and lidocaine, a local anesthetic. This combination is employed primarily for its properties in alleviating symptoms associated with hemorrhoids, anal fissures, and other conditions involving pain and inflammation in the anorectal area.

Indications

  • Hemorrhoids
  • Anal fissures
  • Anorectal pain
  • Venous insufficiency symptoms

Dosage

Children: Refer to the BNF for Children for specific dosing information based on the condition being treated.

Adults: Refer to the BNF for specific dosing information based on the condition being treated.

Mechanism of action

Tribenoside acts by reducing capillary permeability and increasing venous tone, which helps to alleviate symptoms associated with venous insufficiency. Lidocaine works by blocking sodium channels, leading to a temporary loss of sensation in the area where it is applied, thus providing local analgesia.

Pharmacodynamics

The combination of tribenoside and lidocaine provides both symptomatic relief from pain and discomfort while also addressing underlying venous issues. Tribenoside enhances venous return and reduces edema, while lidocaine provides immediate pain relief, making it effective in treating conditions that involve both pain and venous dysfunction.

Pharmacokinetics

After topical application, lidocaine is rapidly absorbed into the systemic circulation, with peak plasma concentrations occurring within 30 minutes to 2 hours. It is metabolized primarily in the liver via cytochrome P450 enzymes. Tribenoside, being a poorly absorbed drug when taken orally, acts locally at the site of application with minimal systemic absorption. The elimination half-life of lidocaine varies between individuals but is generally around 1.5 to 2 hours.

Contra-indications

  • Hypersensitivity to lidocaine or any other local anesthetics
  • Severe heart block
  • Atrioventricular block without a pacemaker
  • Porphyria

Adverse effects

  • Hypotension
  • Bradycardia
  • Dizziness
  • Tinnitus
  • Nausea
  • Allergic reactions
  • Seizures
  • Respiratory depression

Interactions

  • Caution with other antiarrhythmics
  • Increased risk of toxicity with CYP3A4 inhibitors
  • Potentially increased effects with beta-blockers
  • Increased risk of CNS toxicity with other central nervous system depressants

Precautions

  • Use with caution in patients with hepatic impairment
  • Careful monitoring in elderly patients
  • Caution in patients with cardiovascular disease
  • Avoid in patients with history of seizures

Pregnancy

Use only if clearly needed, as lidocaine crosses the placenta. Consult with healthcare provider.

Breast-feeding

Lidocaine is excreted in breast milk; use caution and assess risk versus benefit.

Storage

Store at room temperature, away from light and moisture. Keep out of reach of children.

Formulations

  • Topical gel
  • Injectable solution
  • Transdermal patch

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.